Press releases
Find out more about Ferring latest announcements.
Press releases
-
Ferring Position on Presidential Executive Order on In Vitro Fertilization
-Ferring is encouraged to see President Trump’s Executive Order aimed at finding ways to make in vitro fertilization (IVF) more accessible. With an estimated 1 in 6 people experiencing infertility, IVF is a proven scientific innovation that has helped millions of aspiring parents realize their dream of parenthood. For more than 50 years, Ferring has been at the forefront in […]
-
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
-Independent experience at three Mayo Clinic sites and real-world outcomes data with ADSTILADRIN in patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) to be presented at ASCO GU 2025 Protocols for two ongoing studies from the ADSTILADRIN in BLadder CancEr (ABLE) clinical trial program to be presented at ASCO GU 2025 Real-world data and ABLE clinical trial program […]
-
Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal microbiota, live – jslm)
-FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is widely available with a strong drug supply and dedicated manufacturing facility Since launch, Ferring created REBYOTA @ Home to help patients with rCDI across the U.S. receive treatment at home as well as health care settings Ferring continues to invest in new data, including real-world evidence reinforcing the impact […]